Alliance Global Partners started coverage on shares of SLS International (AMEX:SLS) in a research note issued on Monday, April 8th, MarketBeat.com reports. The brokerage set a “buy” rating and a $4.50 price target on the biotechnology company’s stock.
A number of other brokerages have also recently commented on SLS. Zacks Investment Research raised shares of SLS International from a “sell” rating to a “hold” rating in a research note on Wednesday, January 16th. Maxim Group cut shares of SLS International from a “buy” rating to a “hold” rating in a research note on Friday, March 22nd. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $5.55.
About SLS International
Further Reading: How are dividend achievers different from dividend aristocrats?
Receive News & Ratings for SLS International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SLS International and related companies with MarketBeat.com's FREE daily email newsletter.